Christopher D. Cazenave, an associate in the firm's Business & Commercial Litigation Practice Group in the New Orleans office, recently contributed to the April 2014 issue of Recent Developments, a publication of the Health Care and Pharmaceuticals Committee of the American Bar Association's Antitrust Section. Mr. Cazenave authored two summaries  regarding: (i) a recent settlement of an enforcement action brought by New York's attorney general against two large pharmaceutical companies; and (ii) efforts by a major public-policy group to overturn a newly issued FTC regulation that subjects pharmaceutical companies–but not other industries–to additional notification requirements under the Hart-Scott-Rodino Antitrust Improvements Act. Published six times a year, Recent Developments contains summaries of recent federal and state court cases, government enforcement actions, and other "recent developments" involving antitrust and privacy issues in the healthcare and pharmaceutical industries.